Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (291-300 of 331) with videos related to

Pageof 34
Sort By:
Oncogene|February 1, 1994
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cellsP Rousselot, B Hardas, A Patel, et al.
The Journal of Experimental Medicine|April 6, 1999
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemiaV Lallemand-Breitenbach, M C Guillemin, A Janin, et al.
Biochemical and Biophysical Research Communications|August 4, 1995
Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulationA Agadir, M Cornic, M Jérôme, et al.
The Journal of Experimental Medicine|October 1, 1988
The V gamma locus of the human T cell receptor gamma gene. Repertoire polymorphism of the first variable gene segment subgroupM P Font, Z Chen, J C Bories, et al.
Leukemia|June 1, 1991
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acidP H Wiernik, J P Dutcher, E Paietta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptorsZ Chen, F Guidez, P Rousselot, et al.
Tissue Antigens|November 1, 1983
HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinomaP Herait, T Tursz, M Y Guillard, et al.
Leukemia|February 1, 1994
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patientF Guidez, W Huang, J H Tong, et al.
Lancet (London, England)|September 23, 1989
Retinoic acid therapy for promyelocytic leukaemiaC Chomienne, P Ballerini, N Balitrand, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings]P Solal-Céligny, C Benichou, P Boivin, et al.
Pageof 34

Showing results (291-300 of 331) with videos related to

Sort By:
Pageof 34
Oncogene|February 1, 1994
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cellsP Rousselot, B Hardas, A Patel, et al.
The Journal of Experimental Medicine|April 6, 1999
Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemiaV Lallemand-Breitenbach, M C Guillemin, A Janin, et al.
Biochemical and Biophysical Research Communications|August 4, 1995
Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulationA Agadir, M Cornic, M Jérôme, et al.
The Journal of Experimental Medicine|October 1, 1988
The V gamma locus of the human T cell receptor gamma gene. Repertoire polymorphism of the first variable gene segment subgroupM P Font, Z Chen, J C Bories, et al.
Leukemia|June 1, 1991
Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acidP H Wiernik, J P Dutcher, E Paietta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptorsZ Chen, F Guidez, P Rousselot, et al.
Tissue Antigens|November 1, 1983
HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinomaP Herait, T Tursz, M Y Guillard, et al.
Leukemia|February 1, 1994
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patientF Guidez, W Huang, J H Tong, et al.
Lancet (London, England)|September 23, 1989
Retinoic acid therapy for promyelocytic leukaemiaC Chomienne, P Ballerini, N Balitrand, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings]P Solal-Céligny, C Benichou, P Boivin, et al.
Pageof 34